AI-driven drug discovery collaboration to tackle neurological diseases January 12, 2021 Auto Bot Preclinical Research 0 Sosei Heptares and PharmEnable will harness artificial intelligence-enabled technology and advanced chemistry to explore neurological disease solutions.
